Geron
GERN
#6101
Rank
A$1.40 B
Marketcap
A$2.19
Share price
2.60%
Change (1 day)
-1.20%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -A$77.59 Million

According to Geron's latest financial reports the company's current earnings are A$0.18 Billion. , an increase over its 2024 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 -A$70.54 Million-67.42%
2024 -A$0.22 Billion-11.23%
2023 -A$0.25 Billion30.22%
2022 -A$0.19 Billion20.15%
2021 -A$0.16 Billion50.08%
2020 -A$0.11 Billion4.46%
2019 -A$99.45 Million130.68%
2018 -A$43.11 Million8.84%
2017 -A$39.61 Million-3.08%
2016 -A$40.87 Million-22080.6%
2015 A$0.18 M-100.38%
2014 -A$49.38 Million-7.14%
2013 -A$53.17 Million
2011 -A$0.13 Billion19.04%
2010 -A$0.11 Billion8.45%
2009 -A$97.44 Million-2.51%
2008 -A$99.95 Million14.65%
2007 -A$87.18 Million32.68%
2006 -A$65.71 Million25.59%
2005 -A$52.32 Million4.36%
2004 -A$50.14 Million19.73%
2003 -A$41.87 Million-15.46%
2002 -A$49.53 Million1.94%
2001 -A$48.59 Million33.59%
2000 -A$36.37 Million27.53%
1999 -A$28.52 Million63.13%
1998 -A$17.48 Million15.6%
1997 -A$15.13 Million-10.66%
1996 -A$16.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$13.59 B-19,369.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
A$2.30 B-3,373.71%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-A$96.06 Million 36.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.17 B-342.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.17 Million-81.34%๐Ÿ‡บ๐Ÿ‡ธ USA